GO
Loading...

Takeover Bids

More

  • July 17- Gentiva Health Services Inc rejected Kindred Healthcare Inc's offer to buy a stake in the home healthcare services provider, and said it received a buyout offer from an unnamed party. Gentiva said it got a $17.25 per share buyout offer from "a recognized owner, operator and investor in the sector" on Thursday.

  • Ackman says Valeant-Allergan deal looks closer-CNBC Monday, 21 Jul 2014 | 1:11 PM ET

    July 21- Investor William Ackman, who owns nearly 10 percent of Botox maker Allergan Inc, said on Monday that the likelihood of Valeant Pharmaceuticals International Inc succeeding in its hostile takeover for Allergan increased on Monday.

  • Herbalife shares plunge on Ackman comments     Monday, 21 Jul 2014 | 12:53 PM ET

    Herb Greenberg, CNBC contributor, shares his thoughts on Bill Ackman's comments that Herbalife is a fraud. Let's not forget this is about the business model, says Greenberg.

  • Ackman: Herbalife is going to collapse     Monday, 21 Jul 2014 | 12:45 PM ET
    Bill Ackman

    Pershing Square's Bill Ackman says he'll show evidence that Herbalife is a massive fraud.

  • Ackman: Will not raise offer for Allergan     Monday, 21 Jul 2014 | 12:31 PM ET

    Bill Ackman, Pershing Square, explains why he is not upping his bid for Allergan. The market clearly thinks the chance of Valeant buying Allergan has gone up, says Ackman.

  • Big pharma battle escalates     Monday, 21 Jul 2014 | 12:30 PM ET

    CNBC's Meg Tirrell reports Allergan posted Q2 results that beat on earnings and sales, as the company announced its restructuring plans, which may include an acquisition of its own.

  • Allergan to cut 1,500 employees in restructuring Monday, 21 Jul 2014 | 8:44 AM ET

    Botox maker Allergan will cut about 13 percent of its workforce as part of a push to become more efficient while it fights a hostile takeover bid from Valeant Pharmaceuticals. Allergan Inc. has rejected several takeover attempts from Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman's Pershing Square Capital Management.

  • Early movers: GM, AGN, VRX, HAS, V, MA, IBM & more Monday, 21 Jul 2014 | 8:00 AM ET
    Traders work the floor of the New York Stock Exchange before the closing bell in New York.

    Some of the names on the move ahead of the open.

  • Valeant complains to regulators about Allergan Monday, 21 Jul 2014 | 7:07 AM ET
    Michael Pearson, CEO of Valeant Pharmaceuticals.

    Valeant has complained to regulators that claims made by Allergan to counter a hostile takeover are misleading, sources have told CNBC.

  • July 17- Gentiva Health Services Inc rejected Kindred Healthcare Inc's offer to buy a stake in the home healthcare services provider in favor of a $634.2 million buyout offer from an unnamed party. The offer values Gentiva at about $634.2 million based on the 36.8 million shares outstanding as of March 7.

  • Gentiva gets buyout offer, rejects Kindred's proposal Thursday, 17 Jul 2014 | 4:52 PM ET

    July 17- Gentiva Health Services Inc rejected Kindred Healthcare Inc's offer to buy a stake in the home healthcare services provider in favor of a buyout offer from an unnamed party. Gentiva said it got a $17.25 per share buyout offer from "a recognized owner, operator and investor in the sector" on Thursday.

  • July 17- Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc, has thrown up obstacles to a special shareholders meeting, its biggest investor said on Thursday.

  • July 17- Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc, has stacked the odds against a special shareholders meeting, its biggest investor said on Thursday.

  • SYDNEY, July 17- An Australian court on Thursday approved the takeover of Australia's David Jones Ltd by South Africa's Woolworths Holdings Ltd, clearing a final hurdle for the $2 billion deal. Shareholders of both companies have already voted in favour of the A $4.00 per share bid for Australia' No.2 department store by sales.

  • BOSTON, July 16- To clinch a deal to buy Time Warner Inc, Rupert Murdoch's Twenty-First Century Fox Inc will not only need to raise the value of its bid above $80 billion but also boost its ratio of cash to stock, investors said on Wednesday.

  • Business Highlights Wednesday, 16 Jul 2014 | 5:50 PM ET

    Rejected Fox bid for Time Warner shows growth mood. NEW YORK— In a move that aims to counter consolidation among TV distributors, Rupert Murdoch's Fox has made an unsolicited takeover offer for rival media giant Time Warner for about $76 billion in cash and stock.

  • *Intel gains on earnings, outlook; semiconductors rally. *Time Warner rebuffs $80 bln bid from 21st Century Fox. Time Warner Inc shares jumped 17.1 percent to $83.13 and ranked as the S&P 500' s best performer after Twenty-First Century Fox confirmed it made an $80 billion takeover offer for the company that was turned down.

  • A look at Time Warner and Twenty-First Century Fox Wednesday, 16 Jul 2014 | 1:16 PM ET

    Although Time Warner Inc. said Wednesday that it rejected last month's takeover bid from Twenty-First Century Fox Inc., a person familiar with the matter said that Fox Chairman and CEO Rupert Murdoch is determined, but disciplined, in continuing to pursue a deal.

  • *Intel climbs on earnings, outlook. *Time Warner rebuffs $80 bln bid from 21st Century Fox. Time Warner shares jumped 16.4 percent to $82.63 as the best performer on the S&P 500 after Twenty-First Century Fox confirmed it made an $80 billion takeover offer for the company that was turned down.

  • If Time Warner-FOX deal happens     Wednesday, 16 Jul 2014 | 1:13 PM ET

    CNBC's Julia Boorstin provides insight to the reaction in shares of cable companies after a $80 billion takeover offer from 21st Century Fox for Time Warner was rejected.